HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical presentation and treatment of transfusion-associated babesiosis in premature infants.

Abstract
We review here 7 cases of neonatal transfusion-associated babesiosis at a NICU in the northeast United States. Transfusion from 2 infected units of blood resulted in the 7 cases described. The clinical presentation was highly variable in this cohort; the extremely low birth weight neonates were the most severely affected. Antibiotic therapy was effective in neonates with mild and asymptomatic infection; however, double-volume exchange blood transfusion with prolonged multidrug treatment was required for the 2 most severe cases. The risk of Babesia microti infection is not eliminated through current blood-bank practices. Neonatologists in endemic areas should have a high index of suspicion for babesiosis in premature infants exposed to blood transfusions.
AuthorsKari A Simonsen, Joseph I Harwell, Shabnam Lainwala
JournalPediatrics (Pediatrics) Vol. 128 Issue 4 Pg. e1019-24 (Oct 2011) ISSN: 1098-4275 [Electronic] United States
PMID21890833 (Publication Type: Journal Article)
Topics
  • Babesia microti (isolation & purification)
  • Babesiosis (diagnosis, therapy, transmission)
  • Erythrocyte Transfusion (adverse effects)
  • Humans
  • Infant, Extremely Low Birth Weight
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (diagnosis, parasitology, therapy)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: